Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1832632rdf:typepubmed:Citationlld:pubmed
pubmed-article:1832632lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:1832632lifeskim:mentionsumls-concept:C1299003lld:lifeskim
pubmed-article:1832632lifeskim:mentionsumls-concept:C0221269lld:lifeskim
pubmed-article:1832632lifeskim:mentionsumls-concept:C0017350lld:lifeskim
pubmed-article:1832632lifeskim:mentionsumls-concept:C1511695lld:lifeskim
pubmed-article:1832632pubmed:issue6lld:pubmed
pubmed-article:1832632pubmed:dateCreated1991-10-24lld:pubmed
pubmed-article:1832632pubmed:abstractTextThe organization of immunoglobulin heavy chain (IgH), light chain (kappa and lambda) and T cell receptor (TCR) beta chain gene loci in 10 patients with ocular adnexal pseudolymphoma was investigated. Eight of them showed IgH gene rearrangement in at least one of the 3 restriction enzymes-digested DNAs extracted from ocular adnexal neoplasms. In contrast, none of them exhibited clonal TCR beta chain gene rearrangement. The configuration of bcl-1, bcl-2 and c-myc oncogenes was also studied by Southern blot technique. Two patients had a rearranged joining region, IgH-containing fragment that comigrated with the rearranged bcl-1 fragment. C-myc gene rearrangement was found in only one patient who also had bcl-1 gene rearrangement. In ocular adnexal pseudolymphoma, none demonstrated bcl-2 gene rearrangement; however, in bone marrow cells, one patient with systemic lymphadenopathy exhibited both IgH and bcl-2 gene rearrangements. Three genotypic subsets of these ocular adnexal pseudolymphoma can be identified by the configuration of IgH gene and related oncogenes: with germline configuration of IgH gene and bcl-1, bcl-2 and c-myc oncogenes; with rearrangement of IgH gene but germline configuration of these oncogenes; and with recombination between rearranged IgH and bcl-1 genes. These results suggest in ocular adnexal pseudolymphoma a spectrum of clonal change evolving from polyclonal to monoclonal B-population, and further to monoclonal B-population with rearranged bcl-1, c-myc and/or bcl-2 oncogenes.lld:pubmed
pubmed-article:1832632pubmed:languageenglld:pubmed
pubmed-article:1832632pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:citationSubsetIMlld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832632pubmed:statusMEDLINElld:pubmed
pubmed-article:1832632pubmed:monthJunlld:pubmed
pubmed-article:1832632pubmed:issn0271-3683lld:pubmed
pubmed-article:1832632pubmed:authorpubmed-author:LiuJ HJHlld:pubmed
pubmed-article:1832632pubmed:authorpubmed-author:KAOP CPClld:pubmed
pubmed-article:1832632pubmed:authorpubmed-author:ChenP MPMlld:pubmed
pubmed-article:1832632pubmed:authorpubmed-author:KaoS CSClld:pubmed
pubmed-article:1832632pubmed:authorpubmed-author:HsuW MWMlld:pubmed
pubmed-article:1832632pubmed:issnTypePrintlld:pubmed
pubmed-article:1832632pubmed:volume10lld:pubmed
pubmed-article:1832632pubmed:ownerNLMlld:pubmed
pubmed-article:1832632pubmed:authorsCompleteYlld:pubmed
pubmed-article:1832632pubmed:pagination547-55lld:pubmed
pubmed-article:1832632pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:meshHeadingpubmed-meshheading:1832632-...lld:pubmed
pubmed-article:1832632pubmed:year1991lld:pubmed
pubmed-article:1832632pubmed:articleTitleRearrangements of immunoglobulin gene and oncogenes in ocular adnexal pseudolymphoma.lld:pubmed
pubmed-article:1832632pubmed:affiliationDepartment of Internal Medicine, Veterans General Hospital, Taipei, Taiwan Republic of China.lld:pubmed
pubmed-article:1832632pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1832632pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1832632lld:pubmed